Latest NDRA reports update at 2024-03-28: 20232022
ENDRA Life Sciences  logo

ENDRA Life Sciences NDRA

$ 0.33 -1.6%

Country

usaUSA

IPO year

2017

Industry

Diagnostics research

Stock Exchange

NASDAQ GLOBAL

CEO

Mr. Francois Michelon

Employees in the company

15

Shares

10.4 M

Market Cap[1]

$ 3.43 M

EBITDA (LTM)

$ -12.3 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Diagnostics research"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.